Q: What effect will ABBV’s decision to set the US list price of Viekira Pak at $83.3K (rather than a lower price) have on cumulative sales of Viekira Pak in the US and EU combined over the life of the product?
a) ABBV’s decision will materially INCREASE cumulative Viekira Pak sales in the US+EU. b) ABBV’s decision will materially DECREASE cumulative Viekira Pak sales in the US+EU. c) ABBV’s decision will have NO MATERIAL EFFECT on cumulative sales of Viekira Pak in the US+EU.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.